Xenon Pharmaceuticals (XENE) Competitors $38.63 -0.27 (-0.69%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends XENE vs. RDY, SRPT, CTLT, PCVX, QGEN, ITCI, ROIV, ASND, RVMD, and LNTHShould you be buying Xenon Pharmaceuticals stock or one of its competitors? The main competitors of Xenon Pharmaceuticals include Dr. Reddy's Laboratories (RDY), Sarepta Therapeutics (SRPT), Catalent (CTLT), Vaxcyte (PCVX), Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), Revolution Medicines (RVMD), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry. Xenon Pharmaceuticals vs. Dr. Reddy's Laboratories Sarepta Therapeutics Catalent Vaxcyte Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Revolution Medicines Lantheus Dr. Reddy's Laboratories (NYSE:RDY) and Xenon Pharmaceuticals (NASDAQ:XENE) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment. Do analysts rate RDY or XENE? Dr. Reddy's Laboratories currently has a consensus price target of $17.00, indicating a potential upside of 10.61%. Xenon Pharmaceuticals has a consensus price target of $56.00, indicating a potential upside of 44.97%. Given Xenon Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Xenon Pharmaceuticals is more favorable than Dr. Reddy's Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Reddy's Laboratories 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Xenon Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11 Does the MarketBeat Community prefer RDY or XENE? Xenon Pharmaceuticals received 98 more outperform votes than Dr. Reddy's Laboratories when rated by MarketBeat users. Likewise, 69.95% of users gave Xenon Pharmaceuticals an outperform vote while only 59.33% of users gave Dr. Reddy's Laboratories an outperform vote. CompanyUnderperformOutperformDr. Reddy's LaboratoriesOutperform Votes32159.33% Underperform Votes22040.67% Xenon PharmaceuticalsOutperform Votes41969.95% Underperform Votes18030.05% Do insiders and institutionals hold more shares of RDY or XENE? 3.8% of Dr. Reddy's Laboratories shares are held by institutional investors. Comparatively, 95.4% of Xenon Pharmaceuticals shares are held by institutional investors. 2.0% of Dr. Reddy's Laboratories shares are held by insiders. Comparatively, 5.5% of Xenon Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger earnings and valuation, RDY or XENE? Dr. Reddy's Laboratories has higher revenue and earnings than Xenon Pharmaceuticals. Xenon Pharmaceuticals is trading at a lower price-to-earnings ratio than Dr. Reddy's Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDr. Reddy's Laboratories$299.87B0.04$668M$0.6324.40Xenon Pharmaceuticals$9.43M312.32-$182.39M-$2.82-13.70 Which has more volatility & risk, RDY or XENE? Dr. Reddy's Laboratories has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, Xenon Pharmaceuticals has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Does the media prefer RDY or XENE? In the previous week, Dr. Reddy's Laboratories had 1 more articles in the media than Xenon Pharmaceuticals. MarketBeat recorded 6 mentions for Dr. Reddy's Laboratories and 5 mentions for Xenon Pharmaceuticals. Xenon Pharmaceuticals' average media sentiment score of 0.80 beat Dr. Reddy's Laboratories' score of 0.58 indicating that Xenon Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dr. Reddy's Laboratories 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Xenon Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is RDY or XENE more profitable? Dr. Reddy's Laboratories has a net margin of 17.81% compared to Xenon Pharmaceuticals' net margin of 0.00%. Dr. Reddy's Laboratories' return on equity of 18.53% beat Xenon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Dr. Reddy's Laboratories17.81% 18.53% 13.01% Xenon Pharmaceuticals N/A -24.69%-23.68% SummaryXenon Pharmaceuticals beats Dr. Reddy's Laboratories on 11 of the 19 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XENE vs. The Competition Export to ExcelMetricXenon PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.95B$6.57B$5.06B$9.08BDividend YieldN/A3.11%4.84%4.21%P/E Ratio-13.7010.55102.6717.15Price / Sales312.32195.041,121.74116.80Price / CashN/A57.1641.3037.88Price / Book2.725.104.744.78Net Income-$182.39M$151.51M$119.11M$225.60M7 Day Performance-3.55%-2.13%-1.86%-1.21%1 Month Performance-3.35%-3.13%11.37%3.09%1 Year Performance-6.98%11.54%30.22%16.48% Xenon Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XENEXenon Pharmaceuticals2.8037 of 5 stars$38.63-0.7%$56.00+45.0%-5.8%$2.95B$9.43M-13.70251Insider TradeHigh Trading VolumeRDYDr. Reddy's Laboratories1.8548 of 5 stars$14.77+2.1%$17.00+15.1%+15.8%$12.33B$299.87B22.9527,048Analyst DowngradeNews CoverageSRPTSarepta Therapeutics4.8156 of 5 stars$126.12+1.9%$178.71+41.7%+31.8%$12.05B$1.64B98.971,314Analyst ForecastCTLTCatalent2.7788 of 5 stars$63.48+0.7%$63.40-0.1%N/A$11.52B$4.38B-27.9116,900High Trading VolumePCVXVaxcyte1.6049 of 5 stars$90.42+3.1%$147.50+63.1%+45.4%$11.27BN/A-19.07160Analyst ForecastInsider TradeQGENQiagen3.7415 of 5 stars$45.44+0.1%$51.15+12.6%+3.1%$10.37B$1.97B117.035,967ITCIIntra-Cellular Therapies4.0406 of 5 stars$84.31+1.5%$97.23+15.3%+27.8%$8.94B$612.78M-95.91560ROIVRoivant Sciences3.0012 of 5 stars$12.13+2.4%$17.93+47.8%+16.2%$8.83B$129.13M2.10860Insider TradeASNDAscendis Pharma A/S3.1403 of 5 stars$136.47+5.1%$191.77+40.5%+12.6%$8.28B$327.43M-16.52640RVMDRevolution Medicines4.5467 of 5 stars$44.68-0.7%$63.67+42.5%+71.5%$7.52B$11.58M-12.54443Insider TradeLNTHLantheus4.3768 of 5 stars$94.50+1.6%$130.00+37.6%+53.4%$6.57B$1.50B15.42834Analyst Forecast Related Companies and Tools Related Companies Dr. Reddy's Laboratories Alternatives Sarepta Therapeutics Alternatives Catalent Alternatives Vaxcyte Alternatives Qiagen Alternatives Intra-Cellular Therapies Alternatives Roivant Sciences Alternatives Ascendis Pharma A/S Alternatives Revolution Medicines Alternatives Lantheus Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XENE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XENE Stock Alerts